Turna Ilknur

Turna Ilknur

Auto-generated profile, based on publicly available information

Turna Ilknur

Department of Dermatology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
SASevgi Akarsu
Sevgi Akarsu
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
TITurna Ilknur
Turna Ilknur
FSFatma Semiz
Fatma Semiz
BIBurcu Bahar Inci
Burcu Bahar Inci
EFEmel Fetil
Emel Fetil
Keywords: Dermatitis, atopic; Female; Prurigo

1 March 2018 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
SASevgi Akarsu
Sevgi Akarsu
TITurna Ilknur
Turna Ilknur
EFEmel Fetil
Emel Fetil
A 55-year-old man presented to our clinic with a 16-year history of chronic spontaneous urticaria (CSU). Given the poor response to H1-antihistamines at high doses alone or in combination with montelukast, he had started to receive omalizumab four months ago (300 mg/SC/every fourth week). He was referred to our clinic because of the exacerbation of his urticaria after this therapy. On physical examination, we detected the continuous eruption of short-lived hives on his body and extremities. He had no angioedema. His urticaria activity score-7 (UAS-7) was 14 in the preceding week. Complete blood count, liver, renal, and thyroid function tests, erythrocyte sedimentation rate, C3-C4 complement levels, and urine analysis were normal. Anti-thyroid and antinuclear antibodies, tests for human immunodeficiency, hepatitis B and C viruses, and stool examinations for parasitic infections were negative. Serum IgE level was 196 IU/mL (normal 0-87), and C-reactive protein (CRP) value was 2.2mg/L (normal<5 mg/L). His chest x-ray and abdominal ultrasonography were normal. Twenty-eight days after the last dose, we administered the fifth dose of omalizumab (300mg/SC) because of the ongoing symptoms. We also thought that the previous exacerbations should not be omalizumab-related. No acute reaction was observed following the administration, but an exaggeration of the urticaria and swelling of the lips and tongue were observed after about 12 hours (Figure 1). The CRP value measured in this period was 10.8mg/L. He was treated with antihistamines and systemic corticosteroids, but the UAS-7 was increased to 39 over the first week (Table 1). In the following period, the patient did not accept the diagnostic tests planned to determine the sensitizing compound of omalizumab.

1 February 2015 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
SAS. Akarsu
S. Akarsu
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
TIT. Ilknur
T. Ilknur
BLB. Lebe
B. Lebe
EFE. Fetil
E. Fetil

22 February 2017 in Photodermatology, Photoimmunology & Photomedicine
Verified
Journal Article
Closed access
PDF file
SASevgi Akarsu
Sevgi Akarsu
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
TITurna Ilknur
Turna Ilknur
FSFatma Semiz
Fatma Semiz
EFEmel Fetil
Emel Fetil

1 August 2014
Verified
Closed access
TITurna Ilknur
Turna Ilknur
SASevgi Akarsu
Sevgi Akarsu
SÇSaim Çarsanbali
Saim Çarsanbali
BLBanu Lebe
Banu Lebe
EFEmel Fetil
Emel Fetil

1 April 2017
Verified
Journal Article
Closed access
SASevgi Akarsu
Sevgi Akarsu
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
TITurna Ilknur
Turna Ilknur
FSFatma Semiz
Fatma Semiz
BLBanu Lebe
Banu Lebe
EFEmel Fetil
Emel Fetil